Peer-reviewedCC BY-NC-NDEuropean urology open science6 Oct 2026

Expression of NECTIN-4 and TROP-2 in Resected Upper Tract Urothelial Carcinoma with and Without Preoperative Chemotherapy

Leticia C. Clemente¹
Daniel A. Igel²
Jesse T.R. Spooner²
Shanna M. Pretzsch²
Niki M. Zacharias²
Charles C. Guo³
Surena F. Matin²

¹Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA
²Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA
³Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA

Impact of postoperative chemotherapy in patients resected for esophagogastric adenocarcinoma with major pathological response after preoperative chemotherapy: a study from the FREGAT database
Laure Corazzin, Elodie Jeanbert, Olivier Glehen +26
Therapeutic Advances in Medical Oncology15 Jul 2026Peer-reviewedCC BY 4.0Full textGeneral biology Surgery & anaesthesiaHAL
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu +255
Lancet Oncology8 Sep 2026Peer-reviewedLicence not stated642 citedSurgery & anaesthesiaHAL
Osteoclast-like giant cell variant of bladder urothelial carcinoma with poor response to neoadjuvant chemotherapy managed by robot-assisted radical cystoprostatectomy: A case report
Abdelhakim Oukouhou, Mohamed Tetou, Saad Assila +3
Urology Case Reports12 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Full textOncologyPMCEurope PMC
Bedside Bioimpedance and Simple Functional Tests Identify Muscle Function Impairment Predicting Overall Survival in Chemotherapy-treated Metastatic Urothelial Carcinoma: A Retrospective Pilot Study
NOBUHITO MURAMOTO, KOSUKE KITAMURA, TOMOYA SHIRAKAWA +8
Juntendo Medical Journal1 Sep 2026Peer-reviewedCC BY 4.0Full textGeneral medicinePMCEurope PMC
Extent of lymphadenectomy dictates adjuvant chemotherapy benefit in primarily resected esophageal squamous cell carcinoma: a multi-cohort validation
Yicheng Huang, Xuanhao Lin, Yanhong Lin +1
Frontiers in Oncology29 Oct 2026Peer-reviewedCC BY 4.0OncologyCrossref

Cite

BibTeX

@article{clemente2026expression,
  title = {{Expression of NECTIN-4 and TROP-2 in Resected Upper Tract Urothelial Carcinoma with and Without Preoperative Chemotherapy}},
  author = {Leticia C. Clemente and Daniel A. Igel and Jesse T.R. Spooner and Shanna M. Pretzsch and Niki M. Zacharias and Charles C. Guo and Surena F. Matin},
  journal = {European urology open science},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13673025},
  note = {CC BY-NC-ND},
}

RIS

TY  - JOUR
TI  - Expression of NECTIN-4 and TROP-2 in Resected Upper Tract Urothelial Carcinoma with and Without Preoperative Chemotherapy
AU  - Leticia C. Clemente
AU  - Daniel A. Igel
AU  - Jesse T.R. Spooner
AU  - Shanna M. Pretzsch
AU  - Niki M. Zacharias
AU  - Charles C. Guo
AU  - Surena F. Matin
PY  - 2026
DA  - 2026/10/06
JO  - European urology open science
UR  - https://europepmc.org/article/PMC/PMC13673025
SN  - 2666-1691
SN  - 2666-1683
ER  -

Related

Cite